Is AP26113 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use AP26113? Is AP26113 safe for nursing mother and child? Does AP26113 extracts into breast milk? Does AP26113 has any long term or short term side effects on infants? Can AP26113 influence milk supply or can AP26113 decrease milk supply in lactating mothers?
Answer by DrLact: About AP26113 usage in lactation
No information is available on the clinical use of AP26113 during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during AP26113 therapy and for 1 week after the final dose.
Alternate Drugs
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Fluorouracil(Dangerous)
Cisplatin(Unsafe)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Rituximab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Vincristine(Dangerous)
Letrozole(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Exemestane(Dangerous)
Mitoxantrone(Dangerous)
Trastuzumab(Unsafe)
Mercaptopurine(Safe)
Cladribine(Dangerous)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Cetuximab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)